Alzheimer's soluble amyloid beta is a normal component of human urine

被引:81
作者
Ghiso, J
Calero, M
Matsubara, E
Governale, S
Chuba, J
Beavis, R
Wisniewski, T
Frangione, B
机构
[1] GUNMA UNIV,SCH MED,DEPT NEUROL,MAEBASHI,GUMMA 371,JAPAN
[2] NYU,MED CTR,DEPT PHARMACOL,NEW YORK,NY 10016
[3] NYU,MED CTR,DEPT NEUROL,NEW YORK,NY 10016
关键词
Alzheimer's disease; Down's syndrome; Proteinuria; Sa beta;
D O I
10.1016/S0014-5793(97)00400-6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Soluble A beta (Sa beta) is normally present at a low concentration in human plasma and cerebrospinal fluid. Although the factors involved in the regulation of Sa beta plasma levels are still unknown, me have explored its excretion in the urine as one of the possible homeostatic mechanisms. The presence of Sa beta in the urine was investigated via immunoprecipitation experiments with anti-A beta antibodies followed by detection and identification by immunoblot, MALDI mass spectrometry and sequence analysis. Soluble A beta (4.3 kDa) immunoreactivity was present in the urine of normal donors, Down's syndrome individuals as well as in patients with renal disorders exhibiting glomerular or mixed proteinuria. Edman degradation of the immunoprecipitated material yielded the intact A beta N-terminus and mass spectra analysis indicated the existence of a major component at m/z 4327, corresponding to the molecular mass of A beta 1-40. Semiquantitative data obtained from the immunoprecipitation experiments indicate that under normal conditions the daily excretion of intact Sa beta in the urine represents less than 1% of the circulating pool. (C) 1997 Federation of European Biochemical Societies.
引用
收藏
页码:105 / 108
页数:4
相关论文
共 23 条
[1]   GENERATION OF BETA-AMYLOID IN THE SECRETORY PATHWAY IN NEURONAL AND NONNEURONAL CELLS [J].
BUSCIGLIO, J ;
GABUZDA, DH ;
MATSUDAIRA, P ;
YANKNER, BA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (05) :2092-2096
[2]  
GhersiEgea JF, 1996, J NEUROCHEM, V67, P880
[3]   Intra-arterial infusion of [I-125]A beta 1-40 labels amyloid deposits in the aged primate brain in vivo [J].
Ghilardi, JR ;
Catton, M ;
Stimson, ER ;
Rogers, S ;
Walker, LC ;
Maggio, JE ;
Mantyh, PW .
NEUROREPORT, 1996, 7 (15-17) :2607-2611
[4]   The interaction between apolipoprotein E and Alzheimer's amyloid beta-peptide is dependent on beta-peptide conformation [J].
Golabek, AA ;
Soto, C ;
Vogel, T ;
Wisniewski, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (18) :10602-10606
[5]   AMYLOID BETA-PEPTIDE IS PRODUCED BY CULTURED-CELLS DURING NORMAL METABOLISM [J].
HAASS, C ;
SCHLOSSMACHER, MG ;
HUNG, AY ;
VIGOPELFREY, C ;
MELLON, A ;
OSTASZEWSKI, BL ;
LIEBERBURG, I ;
KOO, EH ;
SCHENK, D ;
TEPLOW, DB ;
SELKOE, DJ .
NATURE, 1992, 359 (6393) :322-325
[6]   THE SOLUBLE FORM OF ALZHEIMERS AMYLOID-BETA PROTEIN IS COMPLEXED TO HIGH-DENSITY-LIPOPROTEIN-3 AND VERY HIGH-DENSITY-LIPOPROTEIN IN NORMAL HUMAN PLASMA [J].
KOUDINOV, A ;
MATSUBARA, E ;
FRANGIONE, B ;
GHISO, J .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1994, 205 (02) :1164-1171
[7]   PASSAGE OF HUMAN AMYLOID BETA-PROTEIN-1-40 ACROSS THE MURINE BLOOD-BRAIN-BARRIER [J].
MANESS, LM ;
BANKS, WA ;
PODLISNY, MB ;
SELKOE, DJ ;
KASTIN, AJ .
LIFE SCIENCES, 1994, 55 (21) :1643-1650
[8]   Blood-brain barrier uptake of the 40 and 42 amino acid sequences of circulating Alzheimer's amyloid beta in guinea pigs [J].
Martel, CL ;
Mackic, JB ;
McComb, JG ;
Ghiso, J ;
Zlokovic, BV .
NEUROSCIENCE LETTERS, 1996, 206 (2-3) :157-160
[9]   CHARACTERIZATION OF APOLIPOPROTEIN J-ALZHEIMERS A-BETA INTERACTION [J].
MATSUBARA, E ;
FRANGIONE, B ;
GHISO, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (13) :7563-7567
[10]   Apolipoprotein J and Alzheimer's amyloid beta solubility [J].
Matsubara, E ;
Soto, C ;
Governale, S ;
Frangione, B ;
Ghiso, J .
BIOCHEMICAL JOURNAL, 1996, 316 :671-679